Work

Activation of CEACAM1 with an agonistic monoclonal antibody results in inhibition of melanoma cells

Year: 2022

Type: article

Source: Cancer Gene Therapy

DOI: 10.1038/s41417-022-00486-x

Authors: Ilan Zaffran, Nadine Landolina, Pratibha Gaur, Tihana Lenac Rovis, Stipan Jonjic, Ofer Mandelboim, Bernhard B. Singer, Francesca Levi-Schaffer

Institutions: Hebrew University of Jerusalem, University of Rijeka, Hadassah Medical Center, University of Duisburg-Essen

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: Israel Cancer Association

Award: G452796199

OpenAlex ID: W4281700692

FWCI: 0.523

Cites: 41

Cited by: 7

Related to: 10